These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2030607)

  • 1. Membrane transport of 1-beta-D-arabinofuranosylcytosine and accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M; Ido M; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M; Taniguchi K; Hamazaki M
    Leuk Res; 1991; 15(4):255-62. PubMed ID: 2030607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M; Ido M; Nagao Y; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M
    Leuk Res; 1991; 15(8):675-81. PubMed ID: 1895749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to 1-beta-D-arabinofuranosylcytosine in P388 murine leukemic cells resistant to etoposide.
    Higashigawa M; Ido M; Ohkubo T; Kawasaki H; Kamiya H; Sakurai M; Taniguchi K; Hamazaki M
    Leuk Res; 1989; 13(1):39-42. PubMed ID: 2915574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
    Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
    Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
    Higashigawa M; Hori H; Ohkubo T; Kawasaki H; Yoshizumi T; Sakurai M
    Med Oncol Tumor Pharmacother; 1990; 7(4):223-6. PubMed ID: 2283889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of 1-beta-D arabinofuranosylcytosine toxicity by 4-nitrobenzyl-6-thioinosine or dipyridamole in human leukemia cell lines.
    Kubota M; Takimoto T; Kitoh T; Tanizawa A; Kiriyama Y; Akiyama Y; Mikawa H
    Anticancer Res; 1988; 8(3):339-42. PubMed ID: 3164609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
    White JC; Hines LH; Rathmell JP
    Cancer Res; 1985 Jul; 45(7):3070-5. PubMed ID: 4005845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chemical modification of nitrobenzylthioinosine on its binding to high-affinity membrane binding sites and inhibition of nucleoside transport.
    Ziemnicka-Merchant B; Aran JM; Plagemann PG; Krafft GA
    Biochem Pharmacol; 1992 Oct; 44(8):1577-83. PubMed ID: 1417982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.
    Horber DH; Schott H; Schwendener RA
    Cancer Chemother Pharmacol; 1995; 36(6):483-92. PubMed ID: 7554040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine.
    Sone S; Ishii K; Tsuruo T
    Cancer Res; 1986 Jun; 46(6):3099-104. PubMed ID: 3698026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
    Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on intracellular kinetics of ara-C triphosphate in HL-60, human leukemia cells in relation to reasonable administration of ara-C].
    Kamiya K; Uchida M; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1419-27. PubMed ID: 2212834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S; Turner A; Nelms P; Yanovich S
    Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine.
    Plagemann PG; Wohlhueter RM
    Biochim Biophys Acta; 1984 Jun; 773(1):39-52. PubMed ID: 6733097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
    Tanaka M; Yoshida S
    Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
    Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.
    Yamauchi T; Kawai Y; Goto N; Kishi S; Imamura S; Yoshida A; Urasaki Y; Fukushima T; Iwasaki H; Tsutani H; Masada M; Ueda T
    Jpn J Cancer Res; 2001 Sep; 92(9):975-82. PubMed ID: 11572766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses.
    Yamauchi T; Kawai Y; Kishi S; Goto N; Urasaki Y; Imamura S; Fukushima T; Yoshida A; Iwasaki H; Tsutani H; Masada M; Ueda T
    Jpn J Cancer Res; 2001 May; 92(5):546-53. PubMed ID: 11376564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.